| Feb 27, 2026 | BrainCheck | $13.0M a | Next Coast Ventures, Michael Smerklo | S3 Ventures, Adele Towers |
| Jan 12, 2026 | Precede Biosciences | $83.5M Debt / Series B | — | 5AM Ventures, Alexandria Venture Investments, Binney Street Capital, Bristol Myers Squibb, Wouter Meuleman, Labcorp, Lilly Asia Ventures, Mirae Asset Capital, Osage University Partners, Tiger Gene, Matthias Kleinz |
| Sep 11, 2025 | Penguin AI | $25.0M Series A | Mark Terbeek | Eric Larsen, John Santelli, Matt Kozlov, California Health Care Foundation, Horizon Blue Cross Blue Shield of New Jersey, ManchesterStory, Overwater Ventures, Robby Peters, Harsha Kapre, Nicholas Reed Shapiro, Watershed VC |
| Jul 1, 2025 | Ultromics | $55.0M Series C | Victor Westerlind, Alastair Stewart, Umur Hursever | HealthQuest Capital, Sandbox Industries, BlueCross BlueShield Venture Partners, Google Ventures, Oxford Science Enterprises, Oxford University, University of Chicago Medicine |
| May 1, 2025 | Carta Healthcare | $18.0M Series B | Brent Burns | Jamison Hill, Embedded Capital, LocalGlobe, Passion Capital, Storm Ventures, Harsh Sinha, Jan Deepen, Stefan Jeschonnek, Tony Jamous, Victor Jacobsson, CU Healthcare Innovation Fund, Navid Farzad, Mass General Brigham Ventures, MemorialCare, Feby Abraham, Paramark Ventures, Rex Health Ventures, TGH Ventures |
| Mar 7, 2024 | BrainCheck | $15.0M Other Equity | Michael Smerklo, S3 Ventures, Nicholas Reed Shapiro | — |
| Feb 21, 2024 | Elektra Health | $3.3M Other Equity | Heffernan | Claire Diaz-Ortiz, Guy Raz, Jenny Fielding, Flare Capital Partners, Seven Seven Six, Monica Jain, MD, FACS |
| Feb 1, 2024 | Sudo Biosciences | $30.0M Series B | — | 5AM Ventures, Access Biotechnology, Adjuvant Capital, Andreessen Horowitz, Frazier Healthcare Partners, Brendan Bulik-Sullivan, Pureos Bioventures, Sanofi Ventures, Versant Ventures, Vincent Brichard, Jonathan Behr, Juergen Eckhardt, Matthias Kleinz |
| Sep 13, 2023 | Sempre Health | $20.0M Other Equity | — | BlueCross BlueShield Venture Partners, Leslie Donato, Jose Guerola, Industry Ventures |
| Jun 1, 2023 | Mozart Therapeutics | $25.0M Series A | ARCH Venture Partners, Soffinova Partners | Leaps by Bayer, MRL Ventures Fund, Takeda Ventures, Lucio Iannone, Jasmina Marjanovic, Alexandria Venture Investments, Altitude Life Science Ventures, Eli Lilly and Company, Ono Venture Investment |
| Mar 1, 2023 | Ring Therapeutics | $87.0M Series C | Flagship Pioneering, Alexandria Venture Investments, Altitude Life Science Ventures, CJ Investment, Invus, Kyowa Kirin, Partners Investment, T. Rowe Price Associates, UPMC Enterprises | — |
| Feb 10, 2023 | Clearsense | $50.0M Series D | Anthony Williams | Health Catalyst Capital |
| Feb 1, 2023 | Cerevance | $51.0M Series B | — | ARCH Venture Partners, Bioluminescence Ventures, David Schenkein, Issi Rozen, GV, Lux Capital, Morgenthaler Ventures, SV Health Investors, Bill Gates, Dementia Discovery Fund, Dolby Family Ventures, Foresite Capital, Gates Frontier, Lightstone Ventures, Takeda Ventures |
| Jan 27, 2023 | Smile Digital Health | $30.0M Series B | UPMC Enterprises | — |
| Sep 1, 2022 | Redesign Health | $65.0M Series C | General Catalyst | BoxGroup, FirstMark Capital, First Round Capital, Montauk Ventures, Seven Seven Six, SignalFire, Sinai Ventures, Marco DeMeireles, Torch Capital, Tusk Venture Partners, Vine Ventures LP, Y Combinator, Karim Atiyeh, Scott Belsky, CVS Health Ventures, Declaration Partners, Eden Global Partners, Euclidean Capital, Samsung Next, TriplePoint Capital |
| Sep 1, 2022 | SparingVision | $75.0M Series B | Sabine Dandiguian, Jeanne Cunicelli | 4BIO Capital, Bpifrance, Rusty Kelley, Stephane Boissel, Ysios Capital |
| Aug 1, 2022 | Novasenta | $40.0M Series A | Jeanne Cunicelli | — |
| Aug 1, 2022 | Abridge | $13.0M Series A | Megh Gupta | Advisors Fund LLC, Asylum Ventures, Bungalow Capital, Collaborative Seed & Growth Partners, Cultivation Capital, Digital Currency Group, Jenny Fielding, Scott Hartley, Fenway Summer, Gaingels, General Catalyst, GreaterGoodSociety, LocalGlobe, MS&AD Ventures, North Island Ventures, O'Reilly AlphaTech Ventures, Otherwise Fund, Pillar VC, Precursor Ventures, Realist Ventures, Sequoia Capital, Union Square Ventures, Vibe Capital, Chris Bennett, Esther Dyson, Mathilde Collin, Oleg Rogynskyy, Sahil Lavingia, Sahin Boydas, Sam Palmisano, Scott Belsky, Zachary Sims, Yoshua Bengio, Bessemer Venture Partners, Robert Bart, Whistler Capital Partners |
| Jun 1, 2022 | Code Biotherapeutics | $75.0M Series A | Northpond Ventures | 4BIO Capital, F-Prime Capital Partners, Generation Ventures, Ed Mathers, New Enterprise Associates, RiverVest, Takeda Ventures, Amgen Ventures, CureDuchenne Ventures, Hatteras Venture Partners, JDRF T1D Fund, UCB Ventures |
| May 1, 2022 | Moxe Health | $30.0M Series B | Vensana Capital, Thomas Schnettler | 3M Ventures, Apollo, Safeguard Scientifics |
| Nov 1, 2021 | BrainCheck | $10.0M Series B | Next Coast Ventures, S3 Ventures | Freestyle Capital, Harrison Metal, Summit Partners, True Wealth Ventures, Nueterra Capital, SelectQuote, Tensility Venture Partners, Adele Towers |
| Jul 1, 2021 | Ring Therapeutics | $120.0M Series B | — | Flagship Pioneering, Altitude Life Science Ventures, Invus, Partners Investment, T. Rowe Price Associates |
| Jun 16, 2021 | Sempre Health | $15.0M Series B | Matt Downs | Industry Ventures, LifeForce Capital, Rethink Impact |
| Apr 1, 2021 | Code Biotherapeutics | $10.0M Seed | 4BIO Capital, Rob Lin, PhD, CFA | F-Prime Capital Partners, Generation Ventures, Ed Mathers, New Enterprise Associates, Northpond Ventures, RiverVest, Takeda Ventures, Debra Miller, JDRF T1D Fund |
| Jan 1, 2021 | Werewolf Therapeutics | $72.0M Series B | Derek DiRocco | RA Capital, Adage Capital Management, Arkin Bio Ventures, CaaS Capital Management, DC Investment Partners, Elise Wang, HBM Healthcare Investments, Longwood Fund, MPM Capital, Soleus Capital, Sphera Healthcare, Taiho Ventures |
